A Two-Center Randomized Trial of an Additional Early Dose of Measles Vaccine: Effects on Mortality and Measles Antibody Levels | Zendy

Ane Bærent Fisker | Zendy; Eric Nébié | Zendy; Anja Schoeps | Zendy; Cesário Martins | Zendy; Amabélia Rodrigues | Zendy; Alphonse Zakané | Zendy; Moubassira Kagoné | Zendy; Stine Byberg | Zendy; Sanne Marie Thysen | Zendy; Justin Tiendrébeogo | Zendy; Boubacar Coulibaly | Zendy; Osman Sankoh | Zendy; Heiko Becher | Zendy; Hilton Whittle | Zendy; Fiona van der Klis | Zendy; Christine Stabell Benn | Zendy; Ali Sié | Zendy; Olaf Müller | Zendy; Peter Aaby | Zendy

Open Access

A Two-Center Randomized Trial of an Additional Early Dose of Measles Vaccine: Effects on Mortality and Measles Antibody Levels

Author(s) -

Ane Bærent Fisker,

Eric Nébié,

Anja Schoeps,

Cesário Martins,

Amabélia Rodrigues,

Alphonse Zakané,

Moubassira Kagoné,

Stine Byberg,

Sanne Marie Thysen,

Justin Tiendrébeogo,

Boubacar Coulibaly,

Osman Sankoh,

Heiko Becher,

Hilton Whittle,

Fiona van der Klis,

Christine Stabell Benn,

Ali Sié,

Olaf Müller,

Peter Aaby

Publication year - 2017

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/cix1033

Subject(s) - medicine , measles , measles vaccine , vaccination , pediatrics , hazard ratio , diphtheria , mortality rate , confidence interval , measles virus , immunology

In addition to protecting against measles, measles vaccine (MV) may have beneficial nonspecific effects. We tested the effect of an additional early MV on mortality and measles antibody levels.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research